Barrett's esophagus and new therapeutic modalities

Therapy

Volumn 4, Issue 6, 2007, Pages 825-840

  Sharma, Virender K ^a   Fleischer, David E ^a  

^a MAYO CLINIC   (United States)

Author keywords

Ablation; Adenocarcinoma; Barrett's cancer; Dysplasia; Endoscopy; Esophagus; Gastroenterology; Intestinal metaplasia; Surveillance

Indexed keywords

ANTACID AGENT; ANTIHISTAMINIC AGENT; ESOMEPRAZOLE; LIDOCAINE; PARACETAMOL; PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER RISK; CANCER STAGING; CATHETER ABLATION; CIRCUMFERENTIAL ABLATION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CRYOTHERAPY; DIGESTIVE TRACT ENDOSCOPY; DISEASE COURSE; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; ELECTROCOAGULATION; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS RESECTION; FOCAL ABLATION; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; LASER SURGERY; MALIGNANT TRANSFORMATION; PATHOPHYSIOLOGY; PATIENT SAFETY; PHOTODYNAMIC THERAPY; PREVALENCE; REVIEW; SQUAMOUS CELL METAPLASIA;

EID: 38049141411     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/14750708.4.6.825     Document Type: Review

References (66)

1. Shaheen N, Ransohoff DR: Gastroesophageal reflux, Barrett's esophagus and esophageal cancer. JAMA 287(15),1972-1981 (2002).
2. Reid BJ: Barrett's esophagus and adenocarcinoma. Gastroenterol. Clin. North Am. 20, 817-834 (1991).
3. Peters JH, Hagen JA DeMeester SR: Barrett's esophagus. J. Gastrointest. Surg. 8(1), 1-17 (2004).
4. Chandrasoma PT, DeMeester TR: GERD: Reflux to Esophageal Adenocarcinoma. Elsevier Inc., MA, USA (2006).
5. Sharma P, Dent J, Armstrong D et al.: The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 131, 1392-1399 (2006).
6. Odze RD: Diagnosis and grading of dysplasia in Barrett's oesophagus. J. Clin. Pathol. 59(10), 1029-1038 (2006).
7. Overholt BF, Lightdale CJ, Wang KK et al.: Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized Phase III trial. Gastrointest. Endosc. 62(4), 488-498 (2005).
8. Imamura M: Superficial Esophageal Neoplasm: Pathology, Diagnosis and Therapy. Springer-Verlag, Tokyo, Japan (2002).
9. Souza RF, Spechler SJ: Concepts in the prevention of adenocarcinoma. of the distal esophagus and proximal stomach. CA Cancer J. Clin. 55, 334-351 (2005).
10. Cooper BT, Chapman W, Neumann CS, Gearty JC: Continuous treatment of Barrett's oesophagus with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Aliment. Pharmacol. Ther. 23, 727-733 (2006).
11. Sharma P, Sampliner RE, Camargo E: Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am. J. Gastroenterol. 92. 582-585 (1997).
12. Ronkainen J, Aro P, Storskrubb T et al.: Prevalence of Barrett's esophagus in the general population: An endoscopic study. Gastroenterology 129, 1825-1831 (2005).
13. Cameron AJ, Zinsmeister AR, Ballard DI, Carney JA: Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroentererology 99, 918-922 (1990).
14. Rex DK, Cummings OW, Shaw MI: Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125, 1670-1677 (2003).
15. Gerson LB, Shetler K, Triadafilopoulos G: Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123, 636-639 (2002).
16. Ward EM, Wolfsen HC, Achem SR et al.: Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am. J. Gastroenterol. 101, 12-17 (2006).
17. Kendall BJ, Whiteman DC: Temporal changes in the endoscopic frequency of new cases of Barrett's esophagus in an australian health region. Am. J. Gastroenterol. 101, 1178-1182 (2006).
18. van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ: Increasing incidence of Barrett's esophagus in the general population. Gut 54, 1062-1066 (2005).
19. Labenz J, Nocon M, Lind T et al.: Prospective follow-up data from the proGERD study suggest that GERD is not a categorical disease. Am. J. Gastro. 101, 2457-2462 (2006).
20. Chandrasoma P, Wickramasinghe K, Ma Y, DeMeester T: Is intestinal metaplasia a necessary precursor lesion for adenocarcinoma of the distal esophagus, gastroesophageal junction and gastric junction? Dis. Esoph. 20, 36-41 (2007).
21. Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin. Gastroenterol. Hepatol. 4, 566-572 (2006).
22. Sampliner RE: Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am. J. Gastronterol. 97(8), 1888-1895 (2002).
23. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS: Is there a publication bias in reporting cancer risk in Barrett's esophagus? Gastroenterology 119, 333-338 (2000).
24. Sharma P, McQuaid K, Dent J et al.: A critical review of the diagnosis and management of Barretts esophagus - the AGA Chicago workshop. Gastroenterology 127, 310-330 (2004).
25. Overholt BF, Lightdale CJ, Wang KK et al.: Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized Phase III trial. Gastrointest. Endosc. 62(4), 488-498 (2005).
26. Wang KK, Sampliner RE: Mucosal ablation in Barrett's esophagus. Mayo Clin. Proc. 76(4), 433-437 (2001).
27. Rohini V, Triadafilopoulos G, Owens D, Kunz P, Sanders GD: Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest. Endosc. 60, 739-756 (2004).
28. Prosst RL, Wolfsen HC, Gahlen J: Photodynamic therapy for esophageal diseases: a clinical update. Endoscopy 35(12), 1059-1068 (2003).
29. Pech O, Gossner L, May A et al.: Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest. Endosc. 62, 24-30 (2005).
30. Wang KK, Wong Kee Song LM, Buttar NS, Papenfuss S, Lutzke L: Barrett's esophagus after photodynamic therapy: risk of cancer development during long term follow up. Gastroenterology 126(Suppl. 2), A50 (2004).
31. Nijhawan PK, Wang KK: Endoscopic mucosal resection of lesions with endoscopic features suggestive of malignancy or high grade dysplasia within Barrett's esophagus. Gastrointest. Endosc. 52, 328-332 (2000).
32. Soetikno RM, Gotoda T, Nakanishi Y, Soehendra N: Endoscopic mucosal resection. Gastrointest. Endosc. 57, 567-579 (2003).
33. Conio M, Cameron AJ, Chak A, Bianchi S, Filiberti R: Endoscopic treatment of high-grade dysplasia and early cancer in Barrett's oesophagus. Lancet Oncol. 6, 311-321 (2005).
34. May A, Gossner L, Behrens A et al.: A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest. Endosc. 58, 167-175 (2003).
35. Ell C, May A, Gossner L et al.: Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118, 670-677 (2000).
36. Seewald S, Akaraviputh T, Seitz U et al.: Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest. Endosc. 57, 854-859 (2003).
37. Rajan E, Gostout CJ, Feitoza AB et al.: Widespread EMR: a new technique for removal of large areas of mucosa. Gastrointest. Endosc. 60, 623-627 (2004).
38. Gossner L, May A, Stolte M, Seitz G, Hahn EG, Ell C: KTP laser destruction of dysplasia and early cancer in columnarlined Barrett's esophagus. Gastrointest. Endosc. 49, 8-12 (1999).
39. Salo JA, Salminen JT, Kiviluoto TA et al.: Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann. Surg. 227, 621-623 (1998).
40. Bonavina L, Ceriani C. Carrazzone A, Segalin A, Ferrero S, Peracchia A: Endoscopic laser ablation of nondysplastic Barrett's epithelium: is it worthwhile? J. Gastrointest. Surg. 3, 194-199 (1999).
41. Barham CP, Jones RL, Biddlestone LR, Hardwick RH, Shepherd NA, Barr H: Photothermal laser ablation of Barrett's oesophagus: endoscopic and histologic evidence of squamous re-epithelialisation. Gut 41, 281-284 (1997).
42. Luman W, Lessels Am Palmer KR: Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's esophagus: a pilot study. Eur. J. Gastroenterol. Hepatol. 8, 627-630 (1996).
43. Weston AP, Sharma P: Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. Am. J. Gastroenterol. 97, 2998-3006 (2002).
44. Manner H, May A, Miehlke S et al.: Ablation of non-neoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation. Am. J. Gastroenterol. 101, 1762-1769 (2006).
45. Tigges H, Fuchs KH, Maroske J. Fein M, Freys S, Muller J: Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus. J. Gastrointest. Surg. 5, 251-259. (2001).
46. Basu KK, Pick B, Bale R, West KP, deCaestecker JS: Efficacy and one year follow-up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut 51. 776-780 (2002).
47. Mosino M, Rebecchi F, Glaccone C, Taraglio S, Sidoli L, Ferraris R: Endoscopic ablation of Barrett's esophagus using argon plasma coagulation (APC) following surgical laparoscopic fundoplication. Surg Endosc. 17, 539-542 (2003).
48. Dulai GS, Jensen DM, Cortina G, Fontana L, Ippoliti A: Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest. Endosc. 61, 232-240 (2005).
49. Montes CG, Brandalise NA, Deliza R, Novais de Magalhaes AF, Ferraz JG: Antireflux surgery followed by bipolar erectrocoagulation in the treatment of Barrett's esophagus. Gastrointest. Endosc. 50, 173-177 (1999).
50. Kovacs BJ, Chen YK, Lewis TD, DeGuzman LJ, Thompson JS: Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression. Gastrointest. Endosc. 49, 547-553 (1999).
51. Sampliner RE, Faij D, Fennerty MB et al.: Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest. Endosc. 53, 554-558 (2001).
52. Fennerty MB, Corless CL, Sheppard B, Faigei DO, Lieberman DA, Sampliner RE: Pathologic documentation of complete elimination of Barrett's metaplasia following multipolar electrocoagulation therapy. Gut 49, 142-144 (2001).
53. Johnston MH, Eastone JA, Horwhat JD, Cartledge J. Mathews JS, Foggy JR: Cryoablation of Barrett's esophagus: a pilot study. Gastruintest. Endosc. 62(6), 842-848 (2005).
54. Ganz RA, Utley DS. Stem RA, Jackson J, Batts KP. Termin P: Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gartrointest. Endosc. 60(6), 1002-1010 (2004).
55. Dunkin BJ, Martinez J, Bejarano PA. Smith CD, Chang K, Melvin WS: Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device (BARRX). Surg Endosc. 20, 125-130 (2006).
56. Smith CD, Bejarano PA, Melvin WS, Patti MG, Muthusamy R, Dunkin BJ. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg. Endosc. 21(4), 560-569 (2007).
57. Sharma VK, Wang KK, Overholt BF et al.: Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest. Endosc. 65, 185-195 (2007).
58. Fleischer DE, Overholt BF, Sharma VK et al.: Long-term (2.5 year) follow-up of the AIM-II trial for ablation of Barrett esophagus: results after primary circumferential ablation followed by secondary focal ablation. Gastrointest. Endosc. 65, AB135 (2007).
59. Sharma VK, Kim HJ, Musil D, Crowell MD, Dean PJ, Fleischer DE: Circumferential ablation of Barrett esophagus with low-grade dysplasia: one and two year follow-up of the AIM-LGD Trial. Gastrointest. Endosc. 65(5), AB155 (2007).
60. Inadomi JM, Madanick RD, Somsouk M, Shaheen NJ: Radiofrequency ablation is more cost-effective than endoscopic surveillance or esophagectomy among patients with Barrett's esophagus and low-grade dysplasia. Gastroenterology 132(4), Supplement S1, A53 (2007).
61. Das A, Wells CD, Fleischer DE, Kim HJ, Sharma VK: Endoscopic ablative therapy is a cost-effective management for non-dysplastic Barrett esophagus. GastroIntest. Endosc. 65, AB151 (2007).
62. Gonorie JJ, Peters F, Curvers WL et al.: Radiofrequency ablation of Barrett's esophagus containing high-grade dysplasia. GastroIntest. Endosc. 65, AB135 (2007).
63. Gondrie JJ, Rygie AM, Sondermeljer C et al.: Balloon-based circumferential ablation followed by focal ablation of Barrett's esophagus containing high-grade dysplasia effectively removes all genetic alterations. Gastroenterology 132 (4), A64 (2007).
64. Beaumont H, Bergman JJ, Pouw R et al.: Preservation of the functional integrity of the distal esophagus after circumferential ablation of Barrett's esophagus. Gastroenterology 132(4), A255 (2007).
65. 360 circumferential ablation is safe and effective for the treatment of Barrett's esophagus and high-grade dysplasia: a US multi-center registry. Gastrointest. Endosc. 65, AB147 (2007).
66. 90 device in 508 cases. Gastrointest. Endosc. 65, AB147 (2007).